Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation
Clinical trial NCT04796441 · UNKNOWN
Trial details
- NCT number
- NCT04796441
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2021-12-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.